1. Ho, Ming-Fen, Zhang, Cheng, Zhang, Lingxin, Li, Hu, Weinshilboum, Richard. 2020. TSPAN5 influences serotonin and kynurenine: pharmacogenomic mechanisms related to alcohol use disorder and acamprosate treatment response. In Molecular psychiatry, 26, 3122-3133. doi:10.1038/s41380-020-0855-9. https://pubmed.ncbi.nlm.nih.gov/32753686/
2. Xie, Qian, Guo, Huiling, He, Peirong, Wu, Yingsong, Li, Ji-Liang. 2021. Tspan5 promotes epithelial-mesenchymal transition and tumour metastasis of hepatocellular carcinoma by activating Notch signalling. In Molecular oncology, 15, 3184-3202. doi:10.1002/1878-0261.12980. https://pubmed.ncbi.nlm.nih.gov/33955149/
3. Moretto, Edoardo, Longatti, Anna, Murru, Luca, Thoumine, Olivier, Passafaro, Maria. . TSPAN5 Enriched Microdomains Provide a Platform for Dendritic Spine Maturation through Neuroligin-1 Clustering. In Cell reports, 29, 1130-1146.e8. doi:10.1016/j.celrep.2019.09.051. https://pubmed.ncbi.nlm.nih.gov/31665629/
4. Roh, Sanghyun, Kim, Sooyoun, Hong, Inpyo, Kim, Chang-Jin, Jeong, Dongjun. 2023. High Expression of Tetraspanin 5 as a Prognostic Marker of Colorectal Cancer. In International journal of molecular sciences, 24, . doi:10.3390/ijms24076476. https://pubmed.ncbi.nlm.nih.gov/37047447/
5. He, Peirong, Wang, Suihai, Zhang, Xuefeng, Jiang, Bo, Li, Ji-Liang. . Tspan5 is an independent favourable prognostic factor and suppresses tumour growth in gastric cancer. In Oncotarget, 7, 40160-40173. doi:10.18632/oncotarget.9514. https://pubmed.ncbi.nlm.nih.gov/27223087/
智鼠故事 
